# Bolger & O'Hearn Inc – FDA Inspection, Dec 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/bolger-ohearn-inc/d6dfe485-981d-43a4-b732-9d35b12a8e61
Source feed: FDA_Inspections

> FDA inspection 1225549 of Bolger & O'Hearn Inc, December 19, 2023. Classification: Official Action Indicated (OAI). 18 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225549
- Company Name: Bolger & O'Hearn Inc
- Inspection Date: 2023-12-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 18

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/armen-h-youssoufian/47aa0283-ca67-4aec-8ac1-7d4cb222eb04)
- [Investigator](https://www.keypedia.com/people/ogechi-c-nna/59452184-8197-4ba6-bf1d-78a7e003ef2c)
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/bolger-ohearn-inc/8e26a8ae-107d-4228-9f9c-506b2b970870

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
